NCT01904747
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
Clinical trial condition
Explore clinical trials studying Lecithin Cholesterol Acyltransferase Deficiency. Study availability and eligibility vary by location and protocol.
NCT01904747
NCT01884909
NCT01827878
NCT01749228
NCT01744873
NCT01735383
NCT01567501
NCT01735344
NCT01722110
NCT01603186